Ridgeline Therapeutics

Ridgeline Therapeutics

US biotechnology company, Ridgeline Therapeutics, is on a mission to reverse age-related decline in muscle strength, which is linked to lower quality-of-life and increased...

  • Stage Series A
  • Amount of raise $8,000,000
  • Pre money valuation $0
Read more
NURO

NURO

Canadian neurotech company NURO is on a mission to help people communicate, using nothing more than the power of their brain. The company has developed a ground breaking...

  • Stage Seed
  • Amount of raise $5,000,000
  • Pre money valuation $0
Read more
Nonagen Therapeutics Corporation

Nonagen Therapeutics Corporation

Nonagen Therapeutics Corporation is an early-stage biopharmaceutical company focused on the development and commercialization of therapeutic candidates to address large market...

  • Stage Seed
  • Amount of raise $7,500,000
  • Pre money valuation $34,000,000
Read more
Human Edge

Human Edge

Human Edge’s disruptive solution for one of the largest global problems today – workplace stress – is personalised at scale using the science of biohacking...

  • Stage Seed
  • Amount of raise $1,500,000
  • Pre money valuation $8,000,000
Read more
FIELD

FIELD

FIELD upgrades the whole brain CPU to facilitate learning and improvement. FIELD technology uses cutting-edge materials, science and ultra-modern electronics to create full brain...

  • Stage Seed
  • Amount of raise $3,500,000
  • Pre money valuation $0
Read more
Deciduous Therapeutics

Deciduous Therapeutics

Deciduous Therapeutics have discovered novel molecules that can activate a critical endogenous immune surveillance mechanism to selectively remove senescent cells and thereby...

  • Stage Seed
  • Amount of raise $5,000,000
  • Pre money valuation $0
Read more
Human People

Human People

Humanpeople is a CQC-regulated preventative health platform, which helps fix everyday health issues and reduce the risk of chronic disease. Essentially humanpeople has put a...

  • Stage Seed
  • Amount of raise £400,000
  • Pre money valuation £2,700,000
Read more
Yuva Biosciences

Yuva Biosciences

Yuva Bioscience’s Advanced Discovery and Development Platform rapidly identifies inducers of mitochondrial health and biogenesis to address aging-related diseases. The company...

  • Stage Seed
  • Amount of raise $2,000,000
  • Pre money valuation $0
Read more
Oxford Drug Design

Oxford Drug Design

Oxford Drug Design, a spinout from the University of Oxford, is an innovative biotechnology company discovering and developing novel therapeutics supported by advanced...

  • Stage Series A
  • Amount of raise £14,000,000
  • Pre money valuation £0
Read more
Mitocholine Header Mitocholine

Mitocholine

Mitocholine’s patented technology addresses mild cognitive impairment (MCI) by bridging the ‘brain energy gap’. Its product is slated to be a key ingredient in a medical food to...

  • Stage Seed
  • Amount of raise £3,500,000
  • Pre money valuation £14,000,000
Read more

Subscribe to our newsletter